ATE32214T1 - Diarylindan-1,3-dione, deren herstellung und verwendung. - Google Patents

Diarylindan-1,3-dione, deren herstellung und verwendung.

Info

Publication number
ATE32214T1
ATE32214T1 AT84201452T AT84201452T ATE32214T1 AT E32214 T1 ATE32214 T1 AT E32214T1 AT 84201452 T AT84201452 T AT 84201452T AT 84201452 T AT84201452 T AT 84201452T AT E32214 T1 ATE32214 T1 AT E32214T1
Authority
AT
Austria
Prior art keywords
diones
diarylindan
preparation
arylindane
inflammatories
Prior art date
Application number
AT84201452T
Other languages
English (en)
Inventor
Alexander Cupples Campbell
Donald Fraser Melven Stevenson
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Application granted granted Critical
Publication of ATE32214T1 publication Critical patent/ATE32214T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/59—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/657—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings
    • C07C49/665—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system
    • C07C49/67—Unsaturated compounds containing a keto groups being part of a ring containing six-membered aromatic rings a keto group being part of a condensed ring system having two rings, e.g. tetralones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/687—Unsaturated compounds containing a keto groups being part of a ring containing halogen
    • C07C49/697—Unsaturated compounds containing a keto groups being part of a ring containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Pens And Brushes (AREA)
  • Indole Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
AT84201452T 1983-10-14 1984-10-10 Diarylindan-1,3-dione, deren herstellung und verwendung. ATE32214T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838327598A GB8327598D0 (en) 1983-10-14 1983-10-14 Pharmacologically active diarylindane-13-diones
EP84201452A EP0138272B1 (de) 1983-10-14 1984-10-10 Diarylindan-1,3-dione, deren Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ATE32214T1 true ATE32214T1 (de) 1988-02-15

Family

ID=10550228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84201452T ATE32214T1 (de) 1983-10-14 1984-10-10 Diarylindan-1,3-dione, deren herstellung und verwendung.

Country Status (16)

Country Link
US (1) US4569945A (de)
EP (1) EP0138272B1 (de)
JP (1) JPS60109541A (de)
KR (1) KR920003101B1 (de)
AT (1) ATE32214T1 (de)
AU (1) AU561309B2 (de)
CA (1) CA1245232A (de)
DE (1) DE3469020D1 (de)
DK (1) DK491984A (de)
ES (1) ES8602582A1 (de)
FI (1) FI82923C (de)
GB (1) GB8327598D0 (de)
GR (1) GR80629B (de)
HU (1) HUT35627A (de)
PT (1) PT79356B (de)
ZA (1) ZA847967B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2556966B1 (fr) * 1983-12-26 1987-09-25 Bouchard Sa Laboratoires Nouvelle application therapeutique d'un derive de l'indane dione et les compositions pharmaceutiques destinees a cet usage
FR2593501B1 (fr) * 1986-01-29 1988-05-06 Panmedica Sa Nouveaux derives bis (r-oxyimino)-5,7 dihydro-6,7 (5h) dibenzo (a,c) cycloheptene, leurs procedes de preparation et leur application comme medicaments
JP2582898B2 (ja) * 1989-05-16 1997-02-19 三菱化学株式会社 インダン―１，３―ジオン誘導体およびこれを有効成分とする除草剤
PT2722322T (pt) 2011-06-16 2019-09-27 Univ Leuven Kath Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral
ES2863985T3 (es) 2012-12-14 2021-10-13 Korea Res Inst Chemical Tech Nuevo compuesto, sal farmacéuticamente aceptable o isómero óptico del mismo, método para prepararlo y composición farmacéutica para la prevención o el tratamiento de enfermedades virales que lo contienen como ingrediente activo
JP7592748B2 (ja) 2020-04-20 2024-12-02 ノバルティス アーゲー 抗ウイルス１，３－ジ－オキソ－インデン化合物
US12083092B2 (en) 2020-04-20 2024-09-10 Novartis Ag Antiviral 1,3-di-oxo-indene compounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2361517A (en) * 1939-09-22 1944-10-31 Gen Electric Sealing apparatus
DE947473C (de) * 1953-04-30 1956-08-16 Geigy Ag J R Verfahren zur Herstellung von 2-(p-Chlorphenyl)-indan-1, 3-dion
DE1130439B (de) * 1960-06-27 1962-05-30 Us Vitamin Pharm Corp Verfahren zur Herstellung von 2-Arylindandionen
BE668871A (de) * 1964-08-27
GB1172696A (en) * 1966-10-20 1969-12-03 Koninklijke Pharma Fab Nv Phenyl-Indandione Derivatives
US3784606A (en) * 1968-08-29 1974-01-08 Pfizer Novel 2-aryl-1,3-indandiones and 2-aryl-2,3-dihydrobenz(f)indene-1,3-diones
US3879468A (en) * 1969-04-14 1975-04-22 Union Carbide Corp 2-(poly substituted phenyl)-1,3-indandione compounds
US3803240A (en) * 1969-04-14 1974-04-09 Union Carbide Corp 2-(2,6-substituted-phenyl)-1,3-indandiones
US3784605A (en) * 1971-05-13 1974-01-08 Union Carbide Corp 2-(polysubstituted phenyl)-1,3-indandione compounds
GB1380089A (en) * 1972-01-20 1975-01-08 Istituto Gentilipisa Spa 2-aryl-1,3-indandiones
US3978231A (en) * 1972-01-25 1976-08-31 Beecham Group Limited Pharmaceutical compositions and method of treating allergic conditions utilizing 2-nitroindane-1,3-dione derivatives as the active agents
US3976681A (en) * 1973-10-12 1976-08-24 Merck & Co., Inc. [1,3-Dioxo-2-substituted and 2,2-disubstituted- indanyloxy (or thio] alkanoic acids
FR2392951A2 (fr) * 1975-02-07 1978-12-29 Creat Lab Nouveaux derives de la ninhydrine, leurs procedes de preparation et medicaments contenant ces derives

Also Published As

Publication number Publication date
AU3418484A (en) 1985-04-18
ZA847967B (en) 1985-05-29
GR80629B (en) 1985-02-12
PT79356B (en) 1986-09-08
GB8327598D0 (en) 1983-11-16
EP0138272B1 (de) 1988-01-27
PT79356A (en) 1984-11-01
AU561309B2 (en) 1987-05-07
US4569945A (en) 1986-02-11
KR920003101B1 (ko) 1992-04-18
HUT35627A (en) 1985-07-29
ES536743A0 (es) 1985-11-16
FI82923B (fi) 1991-01-31
ES8602582A1 (es) 1985-11-16
DK491984A (da) 1985-04-15
CA1245232A (en) 1988-11-22
KR850003382A (ko) 1985-06-17
EP0138272A1 (de) 1985-04-24
FI82923C (fi) 1991-05-10
JPS60109541A (ja) 1985-06-15
DE3469020D1 (en) 1988-03-03
DK491984D0 (da) 1984-10-12
FI844020A0 (fi) 1984-10-12
FI844020L (fi) 1985-04-15

Similar Documents

Publication Publication Date Title
DE3687362D1 (de) Mischungen von fluorenthaltendem polymer, deren herstellung und anwendung.
IT1191150B (it) Virus vaccinico modificato e metodi per la produzione ed uso del medesimo
ATE35416T1 (de) Derivate des glycerophosphocholins und glycerophosphoethanolamins, ihre herstellung und verwendung.
ATE113207T1 (de) Benzamid gegen kognitive erkrankungen.
BR7900905A (pt) Aparelho para o saneamento de liquidos com irradiacao ultravioleta e ozonio
DE3668268D1 (de) Verwendung von cis-n-(2-aminocycloaliphatische) benzen acetamid und benzamid zur herstellung von antikrampfmittel.
ATE32214T1 (de) Diarylindan-1,3-dione, deren herstellung und verwendung.
ES2184774T3 (es) Bifenil-2,2'-diil-bis-difenilfosfinas halogenadas, su preparacion y empleo.
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
FR2420525A1 (fr) Nitriles comportant la structure carbonee du menthane, utilisables en parfumerie
ATA349383A (de) Waessrige wachsdispersionen, deren herstellung und verwendung
AR226767A1 (es) Composiciones fluidas,homogeneas y conformables para fabricar laminas,filamentos o hilos,procedimiento para obtenerlas y procedimiento de conformacion de dichas soluciones
SE8500845L (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
IT1133044B (it) Procedimento per la riduzione della stabilita' termica del caglio microbico
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ATE40782T1 (de) Herstellung von vorkaese und kaese mit hoher trockenmasse.
DE3785555D1 (de) Verwendung von guaifenesin zur behandlung urologischer beschwerden.
ATE89569T1 (de) Haemoglobin mit reduziertem virusrisiko und dessen herstellung.
IT7819623A0 (it) Composizione adatta alla purificazione del sangue e suoi impieghi.
DE3772237D1 (de) Herstellung von sekundaeraminen aus olefinen und primaeraminen.
SU855640A1 (ru) Стабилизированный источник посто нного напр жени
ATE75727T1 (de) Noremopamil, seine herstellung und verwendung.
ATE258T1 (de) Verfahren zur herstellung von 7,8-dichlor-1,2,3,4-tetrahydroisochinolin und zwischenprodukte.
DE58904702D1 (de) Beta-phenoxyethylamine und deren verwendung zur herstellung von farbstoffen.
IT1147764B (it) M -2-one contenenti nelle posizioni 3-e5-centri di asimmetria con la medesima configurazione assoluta e procedimento per la loro preparazione

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties